{"success":true,"data":{"pressRelease":{"id":"126481","rtpr_id":"nNFCbJ2ZxN","ticker":"APPT","exchange":"","all_tickers":["APPT"],"title":"Apptly Announces $1,000,000 Non-Brokered Private Placement","author":"Newsfile Corp","published_at":"2026-08-25T00:00:14.103Z","article_body":"Vancouver, British Columbia--(Newsfile Corp. - August 24, 2026) - Apptly\nHealth Technologies Corp. (CSE: APPT) (FSE: 4KL) (the \"Company\") is pleased to\nannounce that it intends to complete a non-brokered private placement of up to\n8,000,000 units of the Company (the \"Units\"), at a price of $0.125 per Unit,\nfor aggregate gross proceeds of up to $1,000,000 (the \"Offering\"). The Company\nreserves the right to increase the size of the Offering in its sole\ndiscretion. The Offering is not subject to a minimum subscription amount.\n\nEach Unit will consist of one common share of the Company (each, a \"Share\")\nand one common share purchase warrant of the Company (each, a \"Warrant\"). Each\nWarrant entitles the holder thereof to acquire one (1) Share at any time for a\nperiod of twelve (12) months following the closing date of the Offering (the\n\"Closing Date\") at a price of $0.25 per Share, subject to acceleration. If at\nany time following the Closing Date the closing price of the Shares on the\nCanadian Securities Exchange (the \"CSE\") equals or exceeds $0.35 per Share for\nthirty (30) consecutive trading days, the Company may accelerate the expiry\ndate of the Warrants by issuing a news release announcing that the Warrants\nwill expire thirty (30) days following the date of such news release. Any\nWarrants not exercised before the accelerated expiry date will expire and be\nof no further force or effect.\n\n\"Apptly has emerged as a leader in direct-pay healthcare, expanding beyond\nspecialist visits to include outpatient surgical services-all designed to meet\nthe growing demand for affordable, accessible care and employer-direct\ncontracting,\" said Dr. Paula Muto, Founder and Interim CEO. \"What we're seeing\nnow is the emergence of an entire marketplace around direct-pay care, and\ncompanies across this space are increasingly looking to join the Apptly\numbrella. This financing gives us the opportunity to accelerate that momentum,\nbring more high-quality physicians and services into the marketplace, and\nbuild the infrastructure needed to make direct-pay healthcare a more\naccessible and scalable option for employers and patients.\"\n\nIt is expected that the net proceeds from the Offering will be primarily used\nfor general working capital purposes.\n\nAny securities to be issued under the Offering will be subject to a hold\nperiod of four months and one day from the Closing Date in accordance with\napplicable Canadian securities laws and such other further restrictions as may\napply under foreign securities laws.\n\nThe securities offered have not been registered under the U.S. Securities Act\nof 1933, as amended, and may not be offered or sold in the United States\nabsent registration or an applicable exemption from the registration\nrequirements. This news release shall not constitute an offer to sell or the\nsolicitation of an offer to buy nor shall there be any sale of the securities\nin any State in which such offer, solicitation or sale would be unlawful.\n\nAbout Apptly Health Technologies Corp.\n\nApptly Health Technologies Corp. operates UberDoc, a direct-pay healthcare\nmarketplace that connects patients directly with board-certified specialists\nat transparent, upfront prices, with no referral requirements, no insurance\nbarriers, and no surprise bills. With more than 5,000 specialist physicians\nand clinicians across 55-plus specialties in all 50 states, the platform\nprovides patients with faster access to care while enabling physicians to\nexpand patient access and grow their practices. The Company was founded by Dr.\nPaula M. Muto, M.D.\n\nNeither the CSE nor its Market Regulator (as that term is defined in the\npolicies of the CSE) accepts responsibility for the adequacy or accuracy of\nthis release\n\nForward-Looking Statements\n\nThis news release contains certain \"forward-looking information\" and\n\"forward-looking statements\" within the meaning of Canadian securities\nlegislation as may be amended from time to time, including, without\nlimitation, statements regarding the completion of the Offering and\nsatisfaction of any obligations thereunder and the use of proceeds of the\nOffering. Forward-looking statements are statements that are not historical\nfacts which address events, results, outcomes or developments that the Company\nexpects to occur. Forward-looking statements are based on the beliefs,\nestimates and opinions of the Company's management on the date the statements\nare made, and they involve a number of risks and uncertainties. Certain\nmaterial assumptions regarding such forward-looking statements were made,\nincluding without limitation, that there will be no material adverse change\naffecting the Company or its operations; that all required approvals will be\nobtained; that political and legal developments will be consistent with\ncurrent expectations; that currency and exchange rates will be consistent with\ncurrent levels; and that there will be no significant disruptions affecting\nthe Company or its operations. Consequently, there can be no assurances that\nsuch statements will prove to be accurate and actual results and future events\ncould differ materially from those anticipated in such statements.\nForward-looking statements involve significant known and unknown risks and\nuncertainties, which could cause actual results to differ materially from\nthose anticipated. These risks include, but are not limited to risks\nassociated with executing the Company's objectives and strategies, including\ncosts and expenses, as well as those risk factors discussed in the Company's\nmost recently filed management's discussion and analysis, available on\nwww.sedarplus.ca. Except as required by the securities disclosure laws and\nregulations applicable to the Company, the Company undertakes no obligation to\nupdate these forward-looking statements if management's beliefs, estimates or\nopinions, or other factors, should change.\n\nContacts\n\nInvestor Relations / Media\nMeghna Deshraj\nmeghna@uber-docs.com\n973-369-8052\napptlyhealthtech.com (https://api.newsfilecorp.com/redirect/JkVnrUAk0b)\n\nNOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION,\nDISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN\nOR INTO THE UNITED STATES\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/311339","article_body_html":"","raw_payload":{"data":{"id":"nNFCbJ2ZxN","title":"Apptly Announces $1,000,000 Non-Brokered Private Placement","author":"Newsfile Corp","ticker":"APPT","created":"2026-08-25T00:00:14.103Z","tickers":["APPT"],"exchange":"","article_body":"Vancouver, British Columbia--(Newsfile Corp. - August 24, 2026) - Apptly\nHealth Technologies Corp. (CSE: APPT) (FSE: 4KL) (the \"Company\") is pleased to\nannounce that it intends to complete a non-brokered private placement of up to\n8,000,000 units of the Company (the \"Units\"), at a price of $0.125 per Unit,\nfor aggregate gross proceeds of up to $1,000,000 (the \"Offering\"). The Company\nreserves the right to increase the size of the Offering in its sole\ndiscretion. The Offering is not subject to a minimum subscription amount.\n\nEach Unit will consist of one common share of the Company (each, a \"Share\")\nand one common share purchase warrant of the Company (each, a \"Warrant\"). Each\nWarrant entitles the holder thereof to acquire one (1) Share at any time for a\nperiod of twelve (12) months following the closing date of the Offering (the\n\"Closing Date\") at a price of $0.25 per Share, subject to acceleration. If at\nany time following the Closing Date the closing price of the Shares on the\nCanadian Securities Exchange (the \"CSE\") equals or exceeds $0.35 per Share for\nthirty (30) consecutive trading days, the Company may accelerate the expiry\ndate of the Warrants by issuing a news release announcing that the Warrants\nwill expire thirty (30) days following the date of such news release. Any\nWarrants not exercised before the accelerated expiry date will expire and be\nof no further force or effect.\n\n\"Apptly has emerged as a leader in direct-pay healthcare, expanding beyond\nspecialist visits to include outpatient surgical services-all designed to meet\nthe growing demand for affordable, accessible care and employer-direct\ncontracting,\" said Dr. Paula Muto, Founder and Interim CEO. \"What we're seeing\nnow is the emergence of an entire marketplace around direct-pay care, and\ncompanies across this space are increasingly looking to join the Apptly\numbrella. This financing gives us the opportunity to accelerate that momentum,\nbring more high-quality physicians and services into the marketplace, and\nbuild the infrastructure needed to make direct-pay healthcare a more\naccessible and scalable option for employers and patients.\"\n\nIt is expected that the net proceeds from the Offering will be primarily used\nfor general working capital purposes.\n\nAny securities to be issued under the Offering will be subject to a hold\nperiod of four months and one day from the Closing Date in accordance with\napplicable Canadian securities laws and such other further restrictions as may\napply under foreign securities laws.\n\nThe securities offered have not been registered under the U.S. Securities Act\nof 1933, as amended, and may not be offered or sold in the United States\nabsent registration or an applicable exemption from the registration\nrequirements. This news release shall not constitute an offer to sell or the\nsolicitation of an offer to buy nor shall there be any sale of the securities\nin any State in which such offer, solicitation or sale would be unlawful.\n\nAbout Apptly Health Technologies Corp.\n\nApptly Health Technologies Corp. operates UberDoc, a direct-pay healthcare\nmarketplace that connects patients directly with board-certified specialists\nat transparent, upfront prices, with no referral requirements, no insurance\nbarriers, and no surprise bills. With more than 5,000 specialist physicians\nand clinicians across 55-plus specialties in all 50 states, the platform\nprovides patients with faster access to care while enabling physicians to\nexpand patient access and grow their practices. The Company was founded by Dr.\nPaula M. Muto, M.D.\n\nNeither the CSE nor its Market Regulator (as that term is defined in the\npolicies of the CSE) accepts responsibility for the adequacy or accuracy of\nthis release\n\nForward-Looking Statements\n\nThis news release contains certain \"forward-looking information\" and\n\"forward-looking statements\" within the meaning of Canadian securities\nlegislation as may be amended from time to time, including, without\nlimitation, statements regarding the completion of the Offering and\nsatisfaction of any obligations thereunder and the use of proceeds of the\nOffering. Forward-looking statements are statements that are not historical\nfacts which address events, results, outcomes or developments that the Company\nexpects to occur. Forward-looking statements are based on the beliefs,\nestimates and opinions of the Company's management on the date the statements\nare made, and they involve a number of risks and uncertainties. Certain\nmaterial assumptions regarding such forward-looking statements were made,\nincluding without limitation, that there will be no material adverse change\naffecting the Company or its operations; that all required approvals will be\nobtained; that political and legal developments will be consistent with\ncurrent expectations; that currency and exchange rates will be consistent with\ncurrent levels; and that there will be no significant disruptions affecting\nthe Company or its operations. Consequently, there can be no assurances that\nsuch statements will prove to be accurate and actual results and future events\ncould differ materially from those anticipated in such statements.\nForward-looking statements involve significant known and unknown risks and\nuncertainties, which could cause actual results to differ materially from\nthose anticipated. These risks include, but are not limited to risks\nassociated with executing the Company's objectives and strategies, including\ncosts and expenses, as well as those risk factors discussed in the Company's\nmost recently filed management's discussion and analysis, available on\nwww.sedarplus.ca. Except as required by the securities disclosure laws and\nregulations applicable to the Company, the Company undertakes no obligation to\nupdate these forward-looking statements if management's beliefs, estimates or\nopinions, or other factors, should change.\n\nContacts\n\nInvestor Relations / Media\nMeghna Deshraj\nmeghna@uber-docs.com\n973-369-8052\napptlyhealthtech.com (https://api.newsfilecorp.com/redirect/JkVnrUAk0b)\n\nNOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION,\nDISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN\nOR INTO THE UNITED STATES\n\nTo view the source version of this press release, please visit\nhttps://www.newsfilecorp.com/release/311339"},"type":"article","timestamp":"2026-08-25T00:00:14.166428095Z","server_sent_at_ms":1787616014166},"received_at":"2026-08-25T00:00:14.216Z","source_url":"https://www.newsfilecorp.com/release/311339"},"analysis":{"id":"115419","press_release_id":"126481","analysis_json":{"industry":{"label":"Health Care Technology","sector":"Health Care"},"redFlags":["Non-brokered private placement","Use of proceeds is 'general working capital purposes'"],"eventType":"offering","narrative":"Apptly Health Technologies announced a non-brokered private placement of up to 8 million units at $0.125 per unit, targeting aggregate gross proceeds of $1 million.\n\nEach unit consists of one common share and one warrant exercisable at $0.25 for 12 months, with an acceleration trigger at $0.35.\n\nThe proceeds are intended for general working capital purposes.","sentiment":"bearish","agentHooks":{"shouldPost":false,"suggestedAngle":"Micro-cap working capital raise via non-brokered placement."},"keyFigures":{"dealValueUsd":1000000,"offeringPrice":0.125,"sharesOffered":8000000,"customDimensions":{"warrant_term_months":12,"warrant_exercise_price":0.25,"warrant_acceleration_trigger_price":0.35}},"quotedText":"This financing gives us the opportunity to accelerate that momentum, bring more high-quality physicians and services into the marketplace, and build the infrastructure needed to make direct-pay healthcare a more accessible and scalable option for employers and patients.","namedEntities":{"people":[{"name":"Dr. Paula Muto","role":"Founder and Interim CEO"},{"name":"Meghna Deshraj","role":"Investor Relations / Media"}],"products":["UberDoc"],"companies":[{"name":"Apptly Health Technologies Corp.","ticker":"APPT"}],"dollarAmounts":[{"amount":"$1,000,000","context":"aggregate gross proceeds of the Offering"},{"amount":"$0.125","context":"price per Unit"},{"amount":"$0.25","context":"Warrant exercise price per Share"},{"amount":"$0.35","context":"acceleration trigger price per Share"}]},"materialImpact":{"score":2,"reasoning":"Small non-brokered private placement of $1M at a discounted price (assumed given warrant terms), typical for micro-cap working capital raises. Not highly material relative to broader market."},"tickerRelevance":{"others":[],"primary":"APPT"},"globalImportance":5,"audienceRelevance":5,"eventTypeSecondary":[],"importanceComponents":{"dealSize":1000000,"tickerTier":"micro-cap","eventGravity":"micro-cap-financing"}},"event_type":"offering","event_type_secondary":null,"sentiment":"bearish","material_impact_score":2,"narrative":"Apptly Health Technologies announced a non-brokered private placement of up to 8 million units at $0.125 per unit, targeting aggregate gross proceeds of $1 million.\n\nEach unit consists of one common share and one warrant exercisable at $0.25 for 12 months, with an acceleration trigger at $0.35.\n\nThe proceeds are intended for general working capital purposes.","key_figures":{"dealValueUsd":1000000,"offeringPrice":0.125,"sharesOffered":8000000,"customDimensions":{"warrant_term_months":12,"warrant_exercise_price":0.25,"warrant_acceleration_trigger_price":0.35}},"named_entities":{"people":[{"name":"Dr. Paula Muto","role":"Founder and Interim CEO"},{"name":"Meghna Deshraj","role":"Investor Relations / Media"}],"products":["UberDoc"],"companies":[{"name":"Apptly Health Technologies Corp.","ticker":"APPT"}],"dollarAmounts":[{"amount":"$1,000,000","context":"aggregate gross proceeds of the Offering"},{"amount":"$0.125","context":"price per Unit"},{"amount":"$0.25","context":"Warrant exercise price per Share"},{"amount":"$0.35","context":"acceleration trigger price per Share"}]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-08-25T00:00:46.338Z","global_importance":5,"audience_relevance":5,"importance_components":{"dealSize":1000000,"tickerTier":"micro-cap","eventGravity":"micro-cap-financing"}},"durationMs":32114,"modelName":"glm-4.7"}}